Top medical journals accused of skewing research after receiving MILLIONS in ‘bribes’ Several of the top medical journals in the US have found to be raking in millions of dollars from pharmaceutical companies, a practice that calls the reliability of those journals into question.
Nearly two thirds of medical research in the US is underwritten by companies, totaling more than $100 billion annually.
This is potentially problematic because companies have a financial stake in study results and thus could have an incentive to publicly report results that put them in a favorable light and conceal less flattering findings.
Reports have revealed that many top medical journals may be financially motivated to publish the studies that are unfairly skewed in favor of drug firms both through printing fees and payments to journal editors. The Daily Mail
See also:
Nearly two thirds of medical research in the US is underwritten by companies, totaling more than $100 billion annually.
This is potentially problematic because companies have a financial stake in study results and thus could have an incentive to publicly report results that put them in a favorable light and conceal less flattering findings.
Reports have revealed that many top medical journals may be financially motivated to publish the studies that are unfairly skewed in favor of drug firms both through printing fees and payments to journal editors. The Daily Mail
See also:
- The Corruption of Evidence Based Medicine Dr J. Fung blog
No comments:
Post a Comment